Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas

RecruitingOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

September 25, 2023

Primary Completion Date

November 19, 2025

Study Completion Date

March 31, 2026

Conditions
Squamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the Anus
Interventions
OTHER

Multiparameter analysis of each sample

Retrospective and prospective samples will be collected and analyzed for the study of molecular and viral biomarkers. Simultaneously, fibroblastic tumor-associated cells (CAFs) will be isolated from prospective samples. Through co-cultivation with immortalized cell lines derived from anogenital and head-neck SCCs, these CAFs will enable the production of 3D organoids for use in experiments assessing the response to telomerase and deacetylase SIRT1 inhibitors, both in vitro and in preclinical models.

Trial Locations (4)

28100

RECRUITING

Università del Piemonte orientale, Novara

56126

RECRUITING

Azienda Ospedaliera Universitaria Pisana, Pisa

70124

RECRUITING

Istituto Tumori IRCCS Giovanni Paolo II di Bari, Bari

Napoli

RECRUITING

"Istituto Nazionale Tumori , Fondazione Pascale"

All Listed Sponsors
lead

National Cancer Institute, Naples

OTHER